Candida albicans produces large amounts of the acyclic pentitol D-arabitol in culture and in infected animals and humans, and most strains also grow on minimal D-arabitol medium. An earlier study showed that the major metabolic precursor of D-arabitol in C. albicans was D-ribulose-5-PO 4 from the pentose pathway, that C. albicans contained an NAD-dependent D-arabitol dehydrogenase (ArDH), and that the ArDH structural gene (ARD) encoded a 31-kDa short-chain dehydrogenase that catalyzed the reaction D-arabitol ؉ NAD >؍< D-ribulose ؉ NADH. In the present study, we disrupted both ARD chromosomal alleles in C. albicans and analyzed the resulting mutants. The ard null mutation was verified by Southern hybridization, and the null mutant's inability to produce ArDH was verified by Western immunoblotting. The ard null mutant grew well on minimal glucose medium, but it was unable to grow on minimal D-arabitol The human pathogen Candida albicans produces large amounts of D-arabitol in culture and in infected mammalian hosts (3,7,15,27), and most strains also grow on minimal The evidence supporting the conclusions that fungi metabolize D-arabitol via the pathways described above is indirect, consisting mostly of 14 C and 13 C metabolic labeling data and the presence in cell extracts of enzymes with the expected catalytic activities. To our knowledge, it has not yet been shown for any fungus that a defined mutation or a specific enzyme inhibitor interferes with either biosynthesis or utilization of D-arabitol. Therefore, we sought to ascertain more directly the metabolic functions of ArDH in C. albicans. Specifically, we tested the hypothesis that ArDH catalyzes the last step in D-arabitol biosynthesis and the first step in D-arabitol utilization by disrupting both chromosomal alleles of ARD and by analyzing the resulting null mutants.
MATERIALS AND METHODSStrains, media, and plasmids. C. albicans 1161 (arg4 lys1 ser57 MPA1 ura3 gal1) was obtained from S. Scherer (University of Minnesota) (9) and was cultured in yeast extract-peptone supplemented with 1% glucose (YEPD), 1% D-arabitol (YEP/D-arabitol), 1% D-arabinose (YEP/D-arabinose), or no sugar (YEP) (10) or in 0.67% yeast nitrogen base without amino acids (Difco, Detroit, Mich.) supplemented with arginine, lysine, and serine to which 1% glucose (minimal glucose), 1% D-arabitol (minimal D-arabitol), or 1% D-arabinose (minimal D-arabinose) was added. C. albicans transformants were selected on minimal glucose medium plus 1 M sorbitol, and uracil auxotrophs (Ura Ϫ ) were selected on minimal glucose medium supplemented with 625 mg of 5-fluoroorotic acid (FOA) and 100 mg of uridine per liter (FOA medium). Agar (1.5 to 2%) was included as needed.Escherichia coli strains DH5␣ (Gibco BRL, Gaithersburg, Md.) and JM109 (29) were used as plasmid hosts. Cultures were grown in Luria-Bertani medium (20), supplemented with ampicillin (50 g/ml) and/or agar (2%) as needed. E.